Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""TUMOR necrosis factor"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 99702 results
Title:
Circulating TNF receptor levels are associated with estimated glomerular filtration rate even in healthy individuals with normal kidney function.
Authors:
Gohda T; Department of Nephrology, Juntendo University Faculty of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan. .
Murakoshi M; Department of Nephrology, Juntendo University Faculty of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Shibata T; Department of Nephrology, Juntendo University Faculty of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Suzuki Y; Department of Nephrology, Juntendo University Faculty of Medicine, Hongo 2-1-1, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Takemura H; Department of Clinical Laboratory, Juntendo University Hospital, Bunkyo-Ku, Tokyo, Japan.
Tsuchiya K; Department of Clinical Laboratory, Juntendo University Hospital, Bunkyo-Ku, Tokyo, Japan.
Okada T; Department of Clinical Laboratory, Juntendo University Hospital, Bunkyo-Ku, Tokyo, Japan.
Wakita M; Department of Clinical Laboratory, Juntendo University Hospital, Bunkyo-Ku, Tokyo, Japan.
Horiuchi Y; Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, Japan.
Tabe Y; Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, Japan.
Kamei N; Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.; Institute for Clinical Research, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Show more
Source:
Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7245. Date of Electronic Publication: 2024 Mar 27.
Publication Type:
Journal Article
MeSH Terms:
Receptors, Tumor Necrosis Factor, Type II*
Diabetes Mellitus, Type 2*/pathology
Male ; Humans ; Female ; Receptors, Tumor Necrosis Factor, Type I ; Glomerular Filtration Rate/physiology ; Kidney/pathology ; Biomarkers
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Tumor Necrosis Factor-α Receptor 1 Mediates Borna Disease Virus 1-Induced Changes in Peroxisomal and Mitochondrial Dynamics in Neurons.
Authors:
Osei D; Institute for Anatomy and Cell Biology, Justus Liebig University Giessen, 35392 Giessen, Germany.; Institute of Veterinary Pathology, Justus Liebig University Giessen, 35392 Giessen, Germany.
Baumgart-Vogt E; Institute for Anatomy and Cell Biology, Justus Liebig University Giessen, 35392 Giessen, Germany.
Ahlemeyer B; Institute for Anatomy and Cell Biology, Justus Liebig University Giessen, 35392 Giessen, Germany.
Herden C; Institute of Veterinary Pathology, Justus Liebig University Giessen, 35392 Giessen, Germany.; Center for Mind, Brain and Behavior, Justus Liebig University Giessen, 35392 Giessen, Germany.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 03; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 03.
Publication Type:
Journal Article
MeSH Terms:
Receptors, Tumor Necrosis Factor, Type I*/genetics
Borna disease virus*
Mice ; Animals ; Tumor Necrosis Factor-alpha/physiology ; Catalase/genetics ; Antioxidants ; Mitochondrial Dynamics ; Mice, Knockout ; Neurons ; Mice, Inbred C57BL ; Mammals
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α.
Authors:
Perik-Zavodskaia O; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.
Alrhmoun S; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.; Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
Perik-Zavodskii R; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.; Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
Zhukova J; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.; Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
Lopatnikova J; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.; Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
Volynets M; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.
Alshevskaya A; Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
Sennikov S; Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.; Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 06; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 06.
Publication Type:
Journal Article
MeSH Terms:
Receptors, Tumor Necrosis Factor, Type I*/genetics
Receptors, Tumor Necrosis Factor, Type I*/metabolism
Tumor Necrosis Factor-alpha*/metabolism
Humans ; Receptors, Tumor Necrosis Factor, Type II/metabolism ; K562 Cells ; Cytokines/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients.
Authors:
Räth U; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Mester P; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Schwarz H; Department of Physiology, and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, MD9, Singapore 117597, Singapore.
Schmid S; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Müller M; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Buechler C; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Pavel V; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 15; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 15.
Publication Type:
Journal Article
MeSH Terms:
Critical Illness*
Sepsis*/diagnosis
Tumor Necrosis Factor Receptor Superfamily, Member 9*/blood
Tumor Necrosis Factor Receptor Superfamily, Member 9*/chemistry
Humans ; Biomarkers ; Prognosis ; Receptors, Tumor Necrosis Factor ; Renal Dialysis ; Systemic Inflammatory Response Syndrome
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Influence of Race and High Laminar Shear Stress on TNFR1 Signaling in Endothelial Cells.
Authors:
Aldokhayyil M; School of Kinesiology, Auburn University, Auburn, AL 36849, USA.; Department of Physical Therapy, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Gomez DH; School of Kinesiology, Auburn University, Auburn, AL 36849, USA.
Cook MD; Department of Kinesiology, North Carolina Agriculture and Technology State University, Greensboro, NC 27411, USA.
Kavazis AN; School of Kinesiology, Auburn University, Auburn, AL 36849, USA.
Roberts MD; School of Kinesiology, Auburn University, Auburn, AL 36849, USA.
Geetha T; Department of Nutritional Sciences, College of Human Sciences, Auburn University, Auburn, AL 36849, USA.
Brown MD; School of Kinesiology, Auburn University, Auburn, AL 36849, USA.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 29; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 29.
Publication Type:
Journal Article
MeSH Terms:
NF-kappa B*/metabolism
Receptors, Tumor Necrosis Factor, Type I*/genetics
Receptors, Tumor Necrosis Factor, Type I*/metabolism
Child ; Humans ; Cell Adhesion ; Cells, Cultured ; Human Umbilical Vein Endothelial Cells/metabolism ; Monocytes/metabolism ; Signal Transduction/physiology ; Tumor Necrosis Factor-alpha/pharmacology ; Tumor Necrosis Factor-alpha/metabolism ; Race Factors ; Stress, Mechanical
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease.
Authors:
Clark IA; Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
Vissel B; St Vincent's Hospital Centre for Applied Medical Research, St Vincent's Hospital, Darlinghurst, Australia.; UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
Show more
Source:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Oct; Vol. 11 (5), pp. e01136.
Publication Type:
Journal Article; Review
MeSH Terms:
Nervous System Diseases*/drug therapy
Tumor Necrosis Factor-alpha*/physiology
Humans ; Chronic Disease ; Cytokines ; Etanercept/pharmacology ; Etanercept/therapeutic use ; Microglia ; Tumor Necrosis Factor Inhibitors ; Feedback, Physiological
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Infection, Inflammation, and Immunity in Sepsis.
Authors:
Das UN; UND Life Sciences, 2221 NW 5th St., Battle Ground, WA 98604, USA.
Show more
Source:
Biomolecules [Biomolecules] 2023 Aug 31; Vol. 13 (9). Date of Electronic Publication: 2023 Aug 31.
Publication Type:
Journal Article; Review
MeSH Terms:
Tumor Necrosis Factor-alpha*
Sepsis*
Humans ; Interleukin-6 ; Tumor Necrosis Factor Inhibitors ; Inflammation/metabolism ; Fatty Acids, Unsaturated ; Eicosanoids ; Eicosapentaenoic Acid/pharmacology ; Arachidonic Acid ; Cytokines ; Docosahexaenoic Acids ; Anti-Inflammatory Agents
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages.
Authors:
Sheveleva O; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Protasova E; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Nenasheva T; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Butorina N; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Melnikova V; Laboratory of Comparative Developmental Physiology, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Gerasimova T; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Sakovnich O; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Kurinov A; Laboratory of Regeneration Problems, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Grigor'eva E; Laboratory of Developmental Epigenetics, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Lavrentyev Ave., 10, 630090 Novosibirsk, Russia.
Medvedev S; Laboratory of Developmental Epigenetics, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Lavrentyev Ave., 10, 630090 Novosibirsk, Russia.
Lyadova I; Laboratory of Cellular and Molecular Basis of Histogenesis, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilova Str., 26, 119334 Moscow, Russia.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 16; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 16.
Publication Type:
Journal Article
MeSH Terms:
Tumor Necrosis Factor-alpha*
Induced Pluripotent Stem Cells*
Humans ; Tumor Necrosis Factor alpha-Induced Protein 3/genetics ; Macrophages ; Inflammation
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Identification of a novel role for TL1A/DR3 deficiency in acute respiratory distress syndrome that exacerbates alveolar epithelial disruption.
Authors:
Zhang D; Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250021, Shandong, China.
Zhang J; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China.
Zhang J; Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250021, Shandong, China.
Ji X; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China.
Qi Q; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China.
Xu J; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China.
Pan Y; Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250021, Shandong, China.
Liu X; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China.
Sun F; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China.
Zeng R; Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250021, Shandong, China.
Dong L; Department of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, 250021, Shandong, China. .; Department of Respiratory and Intensive Care Unit, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, China. .
Show more
Source:
Respiratory research [Respir Res] 2023 Jul 11; Vol. 24 (1), pp. 182. Date of Electronic Publication: 2023 Jul 11.
Publication Type:
Journal Article
MeSH Terms:
Respiratory Distress Syndrome*/chemically induced
Respiratory Distress Syndrome*/genetics
Receptors, Tumor Necrosis Factor, Member 25*/genetics
Tumor Necrosis Factor Ligand Superfamily Member 15*/genetics
Animals ; Mice ; Epithelium ; Ligands ; Tumor Necrosis Factor-alpha
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS.
Authors:
Pegoretti V; Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, 9747 AG, Groningen, The Netherlands.; Institute of Cell Biology and Immunology, University of Stuttgart, 70569, Stuttgart, Germany.; Stuttgart Research Centre Systems Biology, University of Stuttgart, 70569, Stuttgart, Germany.
Bauer J; Division of Neuroimmunology, Center for Brain Research, Medical University of Vienna, 1090, Vienna, Austria.
Fischer R; Institute of Cell Biology and Immunology, University of Stuttgart, 70569, Stuttgart, Germany.; Stuttgart Research Centre Systems Biology, University of Stuttgart, 70569, Stuttgart, Germany.
Paro I; Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, 9747 AG, Groningen, The Netherlands.
Douwenga W; Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, 9747 AG, Groningen, The Netherlands.
Kontermann RE; Institute of Cell Biology and Immunology, University of Stuttgart, 70569, Stuttgart, Germany.; Stuttgart Research Centre Systems Biology, University of Stuttgart, 70569, Stuttgart, Germany.
Pfizenmaier K; Institute of Cell Biology and Immunology, University of Stuttgart, 70569, Stuttgart, Germany.; Stuttgart Research Centre Systems Biology, University of Stuttgart, 70569, Stuttgart, Germany.
Houben E; Neuroimmune Connections and Repair (NIC&R) Lab, Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, 3590, Hasselt, Belgium.; University MS Centre, 3590, Hasselt/Pelt, Belgium.
Broux B; Neuroimmune Connections and Repair (NIC&R) Lab, Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, 3590, Hasselt, Belgium.; University MS Centre, 3590, Hasselt/Pelt, Belgium.
Hellings N; Neuroimmune Connections and Repair (NIC&R) Lab, Department of Immunology and Infection, Biomedical Research Institute, Hasselt University, 3590, Hasselt, Belgium.; University MS Centre, 3590, Hasselt/Pelt, Belgium.
Baron W; Department Biomedical Sciences of Cells and Systems (BSCS), Section Molecular Neurobiology, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands.
Laman JD; Department Pathology and Medical Biology, University Medical Centre Groningen (UMCG), University of Groningen, 9713 GZ, Groningen, The Netherlands.
Eisel ULM; Department of Molecular Neurobiology, Groningen Institute of Evolutionary Life Science (GELIFES), University of Groningen, 9747 AG, Groningen, The Netherlands. .
Show more
Source:
Journal of neuroinflammation [J Neuroinflammation] 2023 May 03; Vol. 20 (1), pp. 106. Date of Electronic Publication: 2023 May 03.
Publication Type:
Journal Article
MeSH Terms:
Encephalomyelitis, Autoimmune, Experimental*/metabolism
Multiple Sclerosis*/metabolism
Receptors, Tumor Necrosis Factor, Type I*/agonists
Receptors, Tumor Necrosis Factor, Type II*/agonists
Animals ; Humans ; Mice ; Central Nervous System/metabolism ; Inflammation ; Tumor Necrosis Factor-alpha/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Short Peptides of Innate Immunity Protein Tag7 (PGLYRP1) Selectively Induce Inhibition or Activation of Tumor Cell Death via TNF Receptor.
Authors:
Yurkina DM; Institute of Gene Biology (RAS), Moscow 119334, Russia.
Sharapova TN; Institute of Gene Biology (RAS), Moscow 119334, Russia.
Romanova EA; Institute of Gene Biology (RAS), Moscow 119334, Russia.
Yashin DV; Institute of Gene Biology (RAS), Moscow 119334, Russia.
Sashchenko LP; Institute of Gene Biology (RAS), Moscow 119334, Russia.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 12; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 12.
Publication Type:
Journal Article
MeSH Terms:
Cytokines*/metabolism
Neoplasms*
Receptors, Tumor Necrosis Factor, Type I*/genetics
Humans ; Apoptosis ; Immunity, Innate ; Peptides/pharmacology ; Tumor Necrosis Factor-alpha
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease.
Authors:
Salai KHT; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.
Wu LY; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
Chong JR; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
Chai YL; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
Gyanwali B; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
Robert C; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
Hilal S; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117597, Singapore.; Departments of Epidemiology and Radiology & Nuclear Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Venketasubramanian N; Raffles Neuroscience Centre, Raffles Hospital, Singapore 188770, Singapore.
Dawe GS; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.; Precision Medicine Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore.; Neurobiology Programme, Life Sciences Institute, Centre for Life Sciences, National University of Singapore, Singapore 117456, Singapore.
Chen CP; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
Lai MKP; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.; Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
Show more
Source:
Biomolecules [Biomolecules] 2023 Mar 13; Vol. 13 (3). Date of Electronic Publication: 2023 Mar 13.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Tumor Necrosis Factor, Type I*
Cerebral Small Vessel Diseases*
Humans ; Receptors, Tumor Necrosis Factor ; Tumor Necrosis Factor-alpha/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
TNFR2 as a Potential Biomarker for Early Detection and Progression of CKD.
Authors:
Lousa I; Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Reis F; Institute of Pharmacology & Experimental Therapeutics & Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-075 Coimbra, Portugal.
Viana S; Institute of Pharmacology & Experimental Therapeutics & Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-075 Coimbra, Portugal.; Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Pharmacy, 3046-854 Coimbra, Portugal.
Vieira P; Institute of Pharmacology & Experimental Therapeutics & Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-075 Coimbra, Portugal.; Polytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Pharmacy, 3046-854 Coimbra, Portugal.
Vala H; CERNAS, Escola Superior Agrária de Viseu, Instituto Politécnico de Viseu, Campus Politécnico, 3504-510 Viseu, Portugal.; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes e Alto Douro, 5001-801 Vila Real, Portugal.
Belo L; Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Santos-Silva A; Associate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Show more
Source:
Biomolecules [Biomolecules] 2023 Mar 15; Vol. 13 (3). Date of Electronic Publication: 2023 Mar 15.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Tumor Necrosis Factor, Type II*/metabolism
Renal Insufficiency, Chronic*/diagnosis
Rats ; Animals ; Receptors, Tumor Necrosis Factor, Type I/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Tissue Inhibitor of Metalloproteinase-1 ; Biomarkers
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Tumor Necrosis Factor Superfamily 14 (LIGHT) Restricts Neovascularization by Decreasing Circulating Endothelial Progenitor Cells and Function.
Authors:
Hsu CY; Taipei Heart Institute and Division of Cardiology, Department of Internal Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Huang CY; Taipei Heart Institute and Division of Cardiology, Department of Internal Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.; Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City 320, Taiwan.
Shih CM; Taipei Heart Institute and Division of Cardiology, Department of Internal Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Lin YW; Institute of Oral Biology, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Huang PH; Division of Cardiology, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Lin SJ; Taipei Heart Institute and Division of Cardiology, Department of Internal Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Liu CW; Department of Basic Medical Science, College of Medicine, University of Arizona, Phoenix, AZ 85721, USA.
Lin CY; Healthcare Information and Management Department, Ming Chuan University, Taoyuan 333, Taiwan.
Lin FY; Taipei Heart Institute and Division of Cardiology, Department of Internal Medicine, Taipei Medical University, Taipei 110, Taiwan.; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 10; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 10.
Publication Type:
Journal Article
MeSH Terms:
Endothelial Progenitor Cells*/metabolism
Tumor Necrosis Factor Ligand Superfamily Member 14*/metabolism
Animals ; Humans ; Mice ; Cell Movement ; Ischemia/metabolism ; Mice, Inbred C57BL ; Neovascularization, Pathologic/pathology ; Neovascularization, Physiologic ; Nitric Oxide Synthase Type III/metabolism ; Tumor Necrosis Factor-alpha/pharmacology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease.
Authors:
Barrau M; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Duprat M; Department of Immunology, Centre International de Recherche en Infectiologie, Université Claude Bernard Lyon 1, Saint-Etienne, France.
Veyrard P; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Tournier Q; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Williet N; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Marc Phelip J; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Waeckel L; Department of Immunology, Centre International de Recherche en Infectiologie, Université Claude Bernard Lyon 1, Saint-Etienne, France.
Cheifetz AS; Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center , Harvard Medical School, Boston, MA, USA.
Papamichael K; Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center , Harvard Medical School, Boston, MA, USA.
Roblin X; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
Paul S; Department of Immunology, Centre International de Recherche en Infectiologie, Université Claude Bernard Lyon 1, Saint-Etienne, France.
Show more
Source:
Journal of Crohn's & colitis [J Crohns Colitis] 2023 Apr 19; Vol. 17 (4), pp. 633-643.
Publication Type:
Systematic Review; Journal Article
MeSH Terms:
Tumor Necrosis Factor Inhibitors*/therapeutic use
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
Humans ; Tumor Necrosis Factor-alpha ; Infliximab/therapeutic use ; Adalimumab/therapeutic use
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Bistability regulates TNFR2-mediated survival and death of T-regulatory cells.
Authors:
Halder S; Complex Analysis Group, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad, 121001, Haryana, India.
Chatterjee S; Complex Analysis Group, Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad, 121001, Haryana, India. .
Show more
Source:
Journal of biological physics [J Biol Phys] 2023 Mar; Vol. 49 (1), pp. 95-119. Date of Electronic Publication: 2023 Feb 13.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocytes, Regulatory*/metabolism
Receptors, Tumor Necrosis Factor, Type II*/metabolism
Tumor Necrosis Factor-alpha/metabolism ; Signal Transduction ; Immunity
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Specific S100 Proteins Bind Tumor Necrosis Factor and Inhibit Its Activity.
Authors:
Kazakov AS; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Zemskova MY; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.; G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Rystsov GK; G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Vologzhannikova AA; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Deryusheva EI; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Rastrygina VA; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Sokolov AS; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Permyakova ME; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Litus EA; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Uversky VN; Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Permyakov EA; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Permyakov SE; Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2022 Dec 15; Vol. 23 (24). Date of Electronic Publication: 2022 Dec 15.
Publication Type:
Journal Article
MeSH Terms:
Receptors, Tumor Necrosis Factor*/metabolism
S100 Proteins*
S100A12 Protein ; Tumor Necrosis Factor Inhibitors ; Tumor Necrosis Factor-alpha/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Authors:
Salvador-Martín S; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Zapata-Cobo P; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Velasco M; Hospital Universitario Infantil Niño Jesús, 28009 Madrid, Spain.
Palomino LM; Hospital Universitario Infantil Niño Jesús, 28009 Madrid, Spain.
Clemente S; Hospital Vall d'Hebrón, 08035 Barcelona, Spain.
Segarra O; Hospital Vall d'Hebrón, 08035 Barcelona, Spain.
Sánchez C; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Tolín M; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Moreno-Álvarez A; Hospital Universitario A Coruña, 15006 A Coruña, Spain.
Fernández-Lorenzo A; Hospital Universitario A Coruña, 15006 A Coruña, Spain.
Pérez-Moneo B; Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.
Loverdos I; Hospital Universitario Parc Taulí, 08208 Sabadell, Spain.
Navas López VM; Hospital Regional Universitario de Málaga, 29011 Málaga, Spain.
Millán A; Hospital Universitario Virgen de Valme, Universidad de Sevilla, 41014 Sevilla, Spain.
Magallares L; Hospital Universitario la Paz, 28046 Madrid, Spain.
Torres-Peral R; Complejo Asistencial Universitario de Salamanca, 37007 Salamanca, Spain.
García-Romero R; Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.
Pujol-Muncunill G; Servicio de Gastroenterología, Hepatología y Nutrición Pediátrica, Hospital Sant Joan de Dèu, 08950 Barcelona, Spain.
Merino-Bohorquez V; Hospital Universitario Virgen de la Macarena, 41009 Sevilla, Spain.
Rodríguez A; Hospital Universitario Virgen del Rocio, 41013 Sevilla, Spain.
Salcedo E; Hospital Universitario Doce de Octubre, 28041 Madrid, Spain.
López-Cauce B; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Marín-Jiménez I; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.
Menchén L; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.
Laserna-Mendieta E; Departamento of Gastroenterología, Hospital General de Tomelloso, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 28029 Madrid, Spain.; Instituto de Investigación Sanitaria La Princesa, 28006 Madrid, Spain.
Lucendo AJ; Departamento of Gastroenterología, Hospital General de Tomelloso, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 28029 Madrid, Spain.
Sanjurjo-Sáez M; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
López-Fernández LA; Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 16; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 16.
Publication Type:
Multicenter Study; Journal Article
MeSH Terms:
Tumor Necrosis Factor Inhibitors*/therapeutic use
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/genetics
Adult ; Humans ; Child ; Adolescent ; Infliximab/therapeutic use ; Adalimumab/pharmacology ; Adalimumab/therapeutic use ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/therapeutic use ; Polymorphism, Single Nucleotide ; DNA/therapeutic use ; Retrospective Studies
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Plasma Circulating Tumor Necrosis Factor Receptors at Multiple Time Points Can Predict the Outcome of Severe Acute Kidney Injury.
Authors:
Shin DJ; Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea.
Li L; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Intensive Care Unit, Yanbian University Hospital, Yanbian, China.
Cho A; Translational Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea.
Lee J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Oh S; Medical Research Collaborating Center, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Kwon S; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim DK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Kim S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
Oh YK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Lim CS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Kim YS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Lee JP; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Translational Medicine Major, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Show more
Corporate Authors:
VENUS study investigators
Source:
Blood purification [Blood Purif] 2023; Vol. 52 (3), pp. 285-295. Date of Electronic Publication: 2022 Oct 20.
Publication Type:
Journal Article
MeSH Terms:
Receptors, Tumor Necrosis Factor, Type I*
Acute Kidney Injury*/diagnosis
Acute Kidney Injury*/therapy
Humans ; Prospective Studies ; Receptors, Tumor Necrosis Factor ; Biomarkers ; Renal Replacement Therapy ; Retrospective Studies ; Critical Illness
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.
Authors:
Goll R; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Moe ØK; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. .; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway. .
Johnsen KM; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Meyer R; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Friestad J; Department Internal Medicine, Vestre Viken Hospital, Hønefoss, Norway.
Gundersen MD; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Kileng H; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Johnsen K; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department Internal Medicine, Hammerfest Hospital Hammerfest, Tromsø, Norway.
Florholmen JR; Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Gastroenterology, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.; Department Internal Medicine, Vestre Viken Hospital, Hønefoss, Norway.
Show more
Source:
BMC gastroenterology [BMC Gastroenterol] 2022 Nov 17; Vol. 22 (1), pp. 464. Date of Electronic Publication: 2022 Nov 17.
Publication Type:
Journal Article
MeSH Terms:
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/genetics
Crohn Disease*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Tumor Necrosis Factor Inhibitors*/therapeutic use
Humans ; Chronic Disease ; Tumor Necrosis Factor-alpha ; Ustekinumab
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 99702 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.